Literature DB >> 33555506

Transglutaminase 2 mediates transcriptional regulation through BAF250a polyamination.

Hyo-Jun Kim1, Jin-Haeng Lee1, Sung-Yup Cho1,2, Ju-Hong Jeon3,2, In-Gyu Kim4,5,6.   

Abstract

BACKGROUND: Transglutaminase 2 (TG2) mediates protein modifications by crosslinking or by incorporating polyamine in response to oxidative or DNA-damaging stress, thereby regulating apoptosis, extracellular matrix formation, and inflammation. The regulation of transcriptional activity by TG2-mediated histone serotonylation or by Sp1 crosslinking may also contribute to cellular stress responses.
OBJECTIVE: In this study, we attempted to identify TG2-interacting proteins to better understand the role of TG2 in transcriptional regulation.
METHODS: Using a yeast two-hybrid assay to screen a HeLa cell cDNA library, we found that TG2 bound BAF250a, a core subunit of the cBAF chromatin remodeling complex, through an interaction between the TG2 barrel 1 and BAF250a C-terminal domains.
RESULTS: TG2 was pulled down with a GST-BAF250a C-term fusion protein. Moreover, TG2 and BAF250a were co-fractionated using P11 chromatography, and co-immunoprecipitated. A transamidation reaction showed that TG2 mediated incorporation of polyamine into BAF250a. In glucocorticoid response-element reporter-expressing cells, TG2 overexpression increased the luciferase reporter activity in a transamidation-dependent manner. In addition, a comparison of genome-wide gene expression between wild-type and TG2-deficient primary hepatocytes in response to dexamethasone treatment showed that TG2 further enhanced or suppressed the expression of dexamethasone-regulated genes that were identified by a gene ontology enrichment analysis.
CONCLUSION: Thus, our results indicate that TG2 regulates transcriptional activity through BAF250a polyamination.

Entities:  

Keywords:  BAF250a; Dexamethasone; Transamidation; Transcriptional activity; Transglutaminase 2 (TG2)

Mesh:

Substances:

Year:  2021        PMID: 33555506     DOI: 10.1007/s13258-021-01055-6

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   1.839


  34 in total

1.  Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse transcription-polymerase chain reaction with degenerate primers.

Authors:  D Aeschlimann; M K Koeller; B L Allen-Hoffmann; D F Mosher
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

2.  Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.

Authors:  C J Fryer; T K Archer
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

3.  Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.

Authors:  Kihang Choi; Matthew Siegel; Justin L Piper; Liya Yuan; Eun Cho; Pavel Strnad; Bishr Omary; Keith M Rich; Chaitan Khosla
Journal:  Chem Biol       Date:  2005-04

4.  Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine.

Authors:  Ju-Hong Jeon; Kyung-Ho Choi; Sung-Yup Cho; Chai-Wan Kim; Dong-Myung Shin; Joon-Cheol Kwon; Kye-Yong Song; Sang-Chul Park; In-Gyu Kim
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

5.  Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.

Authors:  G-Y Jang; J-H Jeon; S-Y Cho; D-M Shin; C-W Kim; E M Jeong; H C Bae; T W Kim; S-H Lee; Y Choi; D-S Lee; S-C Park; I-G Kim
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

6.  The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.

Authors:  Lingbao Ai; Wan-Ju Kim; Berna Demircan; Lisa M Dyer; Kevin J Bray; Ryan R Skehan; Nicole A Massoll; Kevin D Brown
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

7.  Differential incorporation of biotinylated polyamines by transglutaminase 2.

Authors:  Ju Hong Jeon; Chai Wan Kim; Dong Myung Shin; Kyu il Kim; Sung Yup Cho; Joon Cheol Kwon; Kyung Ho Choi; Heun Soo Kang; In Gyu Kim
Journal:  FEBS Lett       Date:  2003-01-16       Impact factor: 4.124

8.  Gene disruption of tissue transglutaminase.

Authors:  V De Laurenzi; G Melino
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

9.  Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3.

Authors:  Lorna A Farrelly; Robert E Thompson; Shuai Zhao; Ashley E Lepack; Yang Lyu; Natarajan V Bhanu; Baichao Zhang; Yong-Hwee E Loh; Aarthi Ramakrishnan; Krishna C Vadodaria; Kelly J Heard; Galina Erikson; Tomoyoshi Nakadai; Ryan M Bastle; Bradley J Lukasak; Henry Zebroski; Natalia Alenina; Michael Bader; Olivier Berton; Robert G Roeder; Henrik Molina; Fred H Gage; Li Shen; Benjamin A Garcia; Haitao Li; Tom W Muir; Ian Maze
Journal:  Nature       Date:  2019-03-13       Impact factor: 49.962

10.  DDX5 promotes oncogene C3 and FABP1 expressions and drives intestinal inflammation and tumorigenesis.

Authors:  Nazia Abbasi; Tianyun Long; Yuxin Li; Brian A Yee; Benjamin S Cho; Juan E Hernandez; Evelyn Ma; Parth R Patel; Debashis Sahoo; Ibrahim M Sayed; Nissi Varki; Soumita Das; Pradipta Ghosh; Gene W Yeo; Wendy Jia Men Huang
Journal:  Life Sci Alliance       Date:  2020-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.